Skip to main content
. 2021 May 1;13(5):646. doi: 10.3390/pharmaceutics13050646

Figure 9.

Figure 9

Permeability of MEL (2 mg/mL in all samples) and MEL-HSA-P14% nano-formulation across a co-culture model of human RPMI 2650 nasal epithelial cells and vascular endothelial cells (1-h assay). Values are presented as means ± SD, n = 3. *** p < 0.001 significantly different from MEL control.